Shu Y - Search Results

1

NADPH oxidase subunit p22(phox)-mediated reactive oxygen species contribute to angiogenesis and tumor growth through AKT and ERK1/2 signaling pathways in prostate cancer.

Li Q, Fu GB, Zheng JT, He J, Niu XB, Chen QD, Yin Y, Qian X, Xu Q, Wang M, Sun AF, Shu Y, Rui H, Liu LZ, Jiang BH. Li Q, et al. Among authors: shu y. Biochim Biophys Acta. 2013 Dec;1833(12):3375-3385. doi: 10.1016/j.bbamcr.2013.09.018. Epub 2013 Oct 8. Biochim Biophys Acta. 2013. PMID: 24113386 Free article.

2

miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.

Zhu W, Zhu D, Lu S, Wang T, Wang J, Jiang B, Shu Y, Liu P. Zhu W, et al. Among authors: shu y. Med Oncol. 2012 Mar;29(1):384-91. doi: 10.1007/s12032-010-9797-4. Epub 2011 Jan 22. Med Oncol. 2012. PMID: 21258880

3

miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.

Zhu W, Xu H, Zhu D, Zhi H, Wang T, Wang J, Jiang B, Shu Y, Liu P. Zhu W, et al. Among authors: shu y. Cancer Chemother Pharmacol. 2012 Mar;69(3):723-31. doi: 10.1007/s00280-011-1752-3. Epub 2011 Oct 13. Cancer Chemother Pharmacol. 2012. PMID: 21993663

4

Fulvestrant increases gefitinib sensitivity in non-small cell lung cancer cells by upregulating let-7c expression.

Shen H, Liu J, Wang R, Qian X, Xu R, Xu T, Li Q, Wang L, Shi Z, Zheng J, Chen Q, Shu Y. Shen H, et al. Among authors: shu y. Biomed Pharmacother. 2014 Apr;68(3):307-13. doi: 10.1016/j.biopha.2013.10.007. Epub 2013 Nov 7. Biomed Pharmacother. 2014. PMID: 24268810

5

Alteration in Mir-21/PTEN expression modulates gefitinib resistance in non-small cell lung cancer.

Shen H, Zhu F, Liu J, Xu T, Pei D, Wang R, Qian Y, Li Q, Wang L, Shi Z, Zheng J, Chen Q, Jiang B, Shu Y. Shen H, et al. Among authors: shu y. PLoS One. 2014 Jul 24;9(7):e103305. doi: 10.1371/journal.pone.0103305. eCollection 2014. PLoS One. 2014. PMID: 25058005 Free PMC article.

6

CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer.

Qian Y, Pei D, Cheng T, Wu C, Pu X, Chen X, Liu Y, Shen H, Zhang W, Shu Y. Qian Y, et al. Among authors: shu y. Med Oncol. 2015 Mar;32(3):44. doi: 10.1007/s12032-015-0499-9. Epub 2015 Jan 29. Med Oncol. 2015. PMID: 25631633

7

Low miR-145 expression level is associated with poor pathological differentiation and poor prognosis in non-small cell lung cancer.

Shen H, Shen J, Wang L, Shi Z, Wang M, Jiang BH, Shu Y. Shen H, et al. Among authors: shu y. Biomed Pharmacother. 2015 Feb;69:301-5. doi: 10.1016/j.biopha.2014.12.019. Epub 2014 Dec 19. Biomed Pharmacother. 2015. PMID: 25661374

8

TGF-β1 induces erlotinib resistance in non-small cell lung cancer by down-regulating PTEN.

Shen H, Guan D, Shen J, Wang M, Chen X, Xu T, Liu L, Shu Y. Shen H, et al. Among authors: shu y. Biomed Pharmacother. 2016 Feb;77:1-6. doi: 10.1016/j.biopha.2015.10.018. Epub 2015 Nov 28. Biomed Pharmacother. 2016. PMID: 26796257

9

TBX15/miR-152/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination.

Jiang CF, Xie YX, Qian YC, Wang M, Liu LZ, Shu YQ, Bai XM, Jiang BH. Jiang CF, et al. Cancer Cell Int. 2021 Oct 18;21(1):542. doi: 10.1186/s12935-021-02235-w. Cancer Cell Int. 2021. PMID: 34663310 Free PMC article.

10

Epigenetic alterations of CXCL5 in Cr(VI)-induced carcinogenesis.

Ge X, He J, Wang L, Zhao L, Wang Y, Wu G, Liu W, Shu Y, Gong W, Ma XL, Wang Y, Jiang BH, Liu LZ. Ge X, et al. Among authors: shu y. Sci Total Environ. 2022 Sep 10;838(Pt 1):155713. doi: 10.1016/j.scitotenv.2022.155713. Epub 2022 Jun 1. Sci Total Environ. 2022. PMID: 35660107 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,940 results

Search Page

Filters